Published in Cardiovascular Week, September 1st, 2003
The new G3 AED product line costs approximately 30% less to produce than Cardiac Science's current model and the company expects the higher gross margins to translate directly into operating profits.
Cardiac Science president and CEO Raymond W. Cohen said, "We will begin immediate shipments to end users, distributors and OEM...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.